Inicio>>Signaling Pathways>> Immunology/Inflammation>> NF-κB>>4'-hydroxy Chalcone

4'-hydroxy Chalcone (Synonyms: 2-Benzal-4'-hydroxyacetophenone, 2-Benzylidene-4'-hydroxyacetophenone, p-Cinnamoylphenol, NSC 242264)

Catalog No.GC42406

La 4'-hidroxi Chalcona es una chalcona aislada de la raíz de regaliz, con actividad hepatoprotectora.

Products are for research use only. Not for human use. We do not sell to patients.

4'-hydroxy Chalcone Chemical Structure

Cas No.: 2657-25-2

Tamaño Precio Disponibilidad Cantidad
5g
58,00 $
Disponible
10g
105,00 $
Disponible
25g
218,00 $
Disponible
50g
407,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

4'-hydroxy Chalcone is a chalcone metabolite with diverse biological activities. It is formed when chalcone is metabolized by the cytochrome (CYP) P450 isoform CYP1A1 or CYP2C6. 4'-hydroxy Chalcone is estrogenic in MCF-7 cells and is cytotoxic at concentrations higher than 100 nM. It inhibits TNF-α-induced NF-κB signaling and the trypsin-, chymotrypsin-, and caspase-like proteolytic activities of the 26S proteasome in K562 cells in a dose-dependent manner. 4'-hydroxy Chalcone reduces growth of K562, U937, and Jurkat cancer cell lines in a dose-dependent manner without effecting viability of peripheral blood mononuclear cells (PBMCs). It also inhibits glutathione reductase (GSH-RD; IC50 = 47.3 μM) in vitro in a reversible and non-competitive manner.

Reseñas

Review for 4'-hydroxy Chalcone

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 4'-hydroxy Chalcone

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.